As per the IT contract, Cognizant will implement the IT operating environment for the 100,000 Genomes Project. This project will sequence 100,000 whole genomes from NHS patients and their families by 2017.
The project aims to enable new scientific discovery, medical insights and diagnostics. As a result, NHS will be able to offer genomic medicine and personalised treatments to patients with conditions that are currently hard to treat.
As part of a two-year agreement, Cognizant will provide systems integration and analytics services for the technology platform built by Genomics England to augment its capability and capacity to process samples and interpret findings.
An improved technology backbone supported by advanced analytics will also help Genomics England optimise its business processes and simplify the management and analysis of clinical, laboratory and health data.
“Large-scale sequencing initiatives like the UK’s 100,000 Genomes Project require a flexible, secure operating platform to help drive innovation in new diagnostic and treatment options for patients and healthcare providers,” said Bhaskar Sambasivan, vice president of Cognizant’s Life Sciences practice.